Uniquely-licensed UK medical cannabis importer and distributor supplying branded flower and oil products through established UK pharmacy contracts and clinic partnerships, with a roadmap to expand across the EU via a UK and Guernsey distribution hub. The business cites rapid growth (900% since August 2024) and current monthly sales around £900K in 2025, with targets of £2M per month in 2026 and £3M per month in 2027.
Business Highlights
UK Market Growth Engine
- Import and distribution through existing UK pharmacy contracts, plus new clinic and private hospital partnerships
- Exclusive relationships with top-ranked Canadian producers for a custom product line
- Plans to expand readily consumable product formats and derivatives
Traction and Revenue Targets
- 900% revenue growth since August 2024 (stated)
- Existing sales around £900K per month in 2025 (stated)
- Projected UK sales of £2M to £3M per month as scale-up completes (stated)
EU Expansion Strategy
- Planned UK and Guernsey distribution hub to accelerate cross-border logistics into EU markets
- Projected EU revenue of £50M over five years, tied to the Guernsey facility and expanded distribution (stated)
- Expanded wholesale of branded flower, oils, and derivative products across the EU
Margin and Operations Levers
- Focus on lowering COGS via cash purchases and GACP-direct importing
- New co-packing revenue streams planned
Barriers to Entry
- A scarce licensing footprint across the UK and the Channel Islands
- Established supplier relationships and customer and patient access through contracted channels
Investment Opportunity
Seeking £5.5M strategic equity partner to fund UK scale-up and EU hub build-out to drive 10x sales. Strong fit for investors and operators seeking regulated UK market access with a defined EU distribution expansion pathway.
